Keros Therapeutics
KROS
$57.10
Share price
-1.07%
Change (1 day)
23.94%
Change (1 year)
Categories
Operating Margin for Keros Therapeutics (KROS)
Operating Margin as of May 2024 (TTM): -97.74%
According to Keros Therapeutics's latest financial reports and stock price the company's current Operating Margin is -97.74%. At the end of 2021 the company had an Operating Margin of -282.25%.
Operating Margin history for Keros Therapeutics from 2019 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -282.25% | |
| 2019 | -123.36% | 1044.34% |
| 2018 | -10.78% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.